Zenapet Targets Aging Large Breed Mobility Crisis

The report identifies glucosamine and CBD-infused supplements as fastest-growing categories, with 40% year-over-year adoption growth. Owners increasingly seek non-invasive interventions before mobility issues become critical. This trend mirrors human health's shift toward preventive care.

Large breed dogs face unique challenges: hip dysplasia, arthritis, and obesity compound mobility problems. Zenapet's data shows targeted exercise programs combined with supplementation improve mobility scores by 35% in 12 weeks. The findings challenge traditional reactive approaches.

Veterinary partnerships become essential as owners demand science-backed solutions. Brands that integrate diagnostic tools with personalized supplement plans capture premium market segments. Zenapet's strategy positions them at the intersection of pet care and data analytics.

Power Move: Zenapet's mobility data signals a market pivot: pet health is moving from symptom management to predictive wellness. Companies that fail to invest in R&D and owner education will lose share to data-driven competitors. The next battleground is personalized, preventive care at scale.

This article was edited with AI assistance for readability. Read original here.